The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
3110.01
SELADELPAR TREATMENT OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) FOR 2 YEARS IMPROVES THE GLOBE PBC SCORE AND PREDICTS IMPROVED TRANSPLANT-FREE SURVIVAL
Date
May 22, 2022
Explore related products in the following collection:
